S 4918 United States Senate · 118th Congress

Safe and Affordable Drugs from Canada Act of 2024

This bill would allow U.S. individuals to import certain prescription drugs from Canada for personal use, subject to specific safety and eligibility rules. It requires the FDA to establish regulations within 180 days, certifying Canadian pharmacies that meet criteria like being licensed in Canada for at least five years, following quality assurance standards, and not reselling drugs. Imported drugs must match U.S.-approved versions in active ingredients, dosage, and form, and cannot exceed a 90-day supply per person - excluding controlled substances, biologics, and refrigerated drugs. The policy directly affects U.S. consumers seeking lower-cost medications and Canadian pharmacies that qualify for FDA certification.
Bill status in committee 1 of 4 stages cleared
Introduction
Jul 2024
Committee Review
Floor Vote
President
Introduced Jul 31, 2024 Last action Jul 31, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Jul 31, 2024
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Jul 31, 2024
Introduced
Introduced in Senate
upper
1 primary · 7 co-sponsors

Sponsors